Chemours price target lowered to $31 from $40 at Barclays

Barclays lowered the firm’s price target on Chemours to $31 from $40 and keeps an Equal Weight rating on the shares. The analyst negatively revised price targets and earnings estimate for the TiO2 producers following meetings with industry consultant TiPMC and recent conversations with producers. The firm says Tronox (TROX) and Chemours (CC) remain best positioned to ride out the down-cycle, while we think Kronos (KRO) has structural headwinds from Chinese exports.